BE640917A - - Google Patents
Info
- Publication number
- BE640917A BE640917A BE640917A BE640917A BE640917A BE 640917 A BE640917 A BE 640917A BE 640917 A BE640917 A BE 640917A BE 640917 A BE640917 A BE 640917A BE 640917 A BE640917 A BE 640917A
- Authority
- BE
- Belgium
- Prior art keywords
- emi
- quo
- present
- group
- amino group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
<EMI ID=1.1>
La présente Invention concerne un nouveau
<EMI ID=2.1>
<EMI ID=3.1>
<EMI ID=4.1>
On prépare ce nouveau composé on faisant
réagir un soit en particulier un sol alcalin, d'un
<EMI ID=5.1>
<EMI ID=6.1>
dont laquelle
<EMI ID=7.1>
lisation fractionnée, et on transformant, s'il est nécessaire, le groupe X on groupe amine libre. On effectua les réactions par exemple on chauffant dans
<EMI ID=8.1>
auquel cas il pourra s'agir, par exemple, du groupe nitro ou do restes contenant des groupes azo substitues,
<EMI ID=9.1>
<EMI ID=10.1>
contiennent un reste X, hydrolysable on groupe amino, on peut effectuer l'hydrolyse du produit do 'condensation,
<EMI ID=11.1>
l'hydrolyse des composes alcoxycarbonylamino se fera également dans des conditions alcalinos douces, par
<EMI ID=12.1>
pyrimidino convient pour la préparation dos médicaments à usage interne et externe, destines par exemple au
<EMI ID=13.1>
i <EMI ID=14.1>
on solutions aqueuses pour injections, sous forma de
ses sols, par exemple do ses sels do sodium, do potassium, do lithium, do magnésium ou do calcium, ou encore sous
<EMI ID=15.1>
L'exemple suivant illustre la présente invention sans aucunomont on limiter la portée" EXEMPLE
<EMI ID=16.1> <EMI ID=17.1>
<EMI ID = 1.1>
The present invention relates to a new
<EMI ID = 2.1>
<EMI ID = 3.1>
<EMI ID = 4.1>
We prepare this new compound by doing
react either in particular an alkaline sol, a
<EMI ID = 5.1>
<EMI ID = 6.1>
which one
<EMI ID = 7.1>
fractionalization, and transforming, if necessary, the group X or the free amine group. The reactions were carried out for example by heating in
<EMI ID = 8.1>
in which case it may be, for example, the nitro group or residues containing substituted azo groups,
<EMI ID = 9.1>
<EMI ID = 10.1>
contain a residue X, hydrolyzable or an amino group, the hydrolysis of the condensation product can be carried out,
<EMI ID = 11.1>
the hydrolysis of the alkoxycarbonylamino compounds will also take place under mild alkaline conditions, for example
<EMI ID = 12.1>
pyrimidino is suitable for the preparation of medicaments for internal and external use, for example intended for
<EMI ID = 13.1>
i <EMI ID = 14.1>
on aqueous solutions for injections, in the form of
its soils, for example of its sodium, potassium, lithium, magnesium or calcium salts, or
<EMI ID = 15.1>
The following example illustrates the present invention without any limitation on the scope "EXAMPLE
<EMI ID = 16.1> <EMI ID = 17.1>
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1445562 | 1962-12-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE640917A true BE640917A (en) | 1964-06-08 |
Family
ID=4400963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE640917A BE640917A (en) | 1962-12-07 | 1963-12-06 |
Country Status (5)
| Country | Link |
|---|---|
| AT (1) | AT245574B (en) |
| BE (1) | BE640917A (en) |
| ES (2) | ES294233A1 (en) |
| FR (2) | FR1377697A (en) |
| NL (1) | NL301455A (en) |
-
0
- NL NL301455D patent/NL301455A/xx unknown
-
1963
- 1963-12-06 ES ES294233D patent/ES294233A1/en not_active Expired
- 1963-12-06 AT AT979663A patent/AT245574B/en active
- 1963-12-06 BE BE640917A patent/BE640917A/fr unknown
- 1963-12-06 FR FR956265A patent/FR1377697A/en not_active Expired
- 1963-12-06 ES ES0294233A patent/ES294233A2/en not_active Expired
-
1964
- 1964-03-05 FR FR966168A patent/FR3299M/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL301455A (en) | 1900-01-01 |
| AT245574B (en) | 1966-03-10 |
| FR1377697A (en) | 1964-11-06 |
| ES294233A2 (en) | 1964-05-16 |
| FR3299M (en) | 1965-05-10 |
| ES294233A1 (en) | 1964-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8501415A1 (en) | Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin | |
| KR890000349A (en) | Zircon oxide mixture and preparation method | |
| GB1327312A (en) | Hererocyclic compounds | |
| IE43653L (en) | Sequestration of oxygen dissolved in water | |
| GB1178034A (en) | Hydroxy-Cyclohexylamines | |
| BE640917A (en) | ||
| ES438451A1 (en) | Aminotetralols | |
| FR2418199A1 (en) | FIBROUS MAGNESIUM HYDROXIDE CRYSTALLIZED IN THE HEXAGONAL SYSTEM | |
| KR850001160A (en) | Method for preparing polyhydroxy benzoic acid derivative | |
| KR830004219A (en) | Pharmacologically active peptide | |
| ES460351A1 (en) | 2-Bromo-6-fluoro-N-(2-imidazolidinylidene)-benzamine and salts thereof and the use to treat hypertension | |
| IE45222L (en) | 2-loweralkyl-2- or -3-cephem-4-carboxylic acids. | |
| SE8103106L (en) | PROCEDURE FOR THE PREPARATION OF 4A-ARYL-OCTAHYDRO-1H-2-PYRINDINES | |
| IE34326B1 (en) | Phenylaminoethanol derivatives | |
| KR840004361A (en) | Plant extracts of the family "Hypoxidesi" (Hypoxidaceae) for the treatment of cancer | |
| ES8206484A1 (en) | N-(amino(or hydroxy) phenethyl)-1,2,3,4-tetrahydroisoquinolines, precursors thereof, and methods of preparation. | |
| US3131197A (en) | 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone | |
| JPS57153077A (en) | Heat accumulating material | |
| CA2018149A1 (en) | Aminoketone compounds | |
| KR840004090A (en) | Method for preparing dimethyl acetamide solvate of thin- (2-aminothiazol-4-yl) (methoxyimino) acetic acid | |
| FR2403345A1 (en) | PROCESS FOR OBTAINING PURE 7- (D-MANDELAMIDO) -3- (1-METHYL-1,2,3,4-TETRAZOL-5-YL) THIOMETHYL-3-CEPHEM-4-CARBOXYLIC ACID FROM ITS SALTS | |
| FR2493M (en) | ||
| GB1182647A (en) | Reduction of Nitrophenyl Compounds | |
| Le Noble et al. | The effect of pressure on the rate of fragmentation on/gb-bromoangelate ion | |
| GB1319650A (en) | Low temperature chlorination of acetoacetamides |